NCT05803226 (SAP) is a NA clinical trial of Slow Art Plus in Mental Health Wellness 1, sponsored by Nanyang Technological University.

Who is sponsoring NCT05803226?

NCT05803226 is sponsored by Nanyang Technological University.

What drugs are being tested in NCT05803226?

Interventions in NCT05803226: Slow Art Plus.

What condition does NCT05803226 study?

NCT05803226 studies Mental Health Wellness 1, Self Care, Compassion.

Is NCT05803226 still recruiting?

NCT05803226 is currently status unknown. Last updated 7 April 2023.

Last reviewed 2023-04-07 · How we verify

NCT05803226: SAP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Slow Art Plus: A Single Session Art Gallery-based Intervention for Mental Health Promotion

Status unknown NA Last updated 7 April 2023

What this trial tests

NA trial testing Slow Art Plus in Mental Health Wellness 1 in 200 participants. Status unknown.

Timeline

14 July 2022

Primary endpoint
31 December 2023

31 December 2024

Quick facts

Lead sponsor	Nanyang Technological University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	200
Start date	14 July 2022
Primary completion	31 December 2023
Estimated completion	31 December 2024
Sites	1 location across Singapore

Drugs / interventions tested

Slow Art Plus

Conditions studied

Mental Health Wellness 1 — all drugs for Mental Health Wellness 1 →
Self Care — all drugs for Self Care →
Compassion — all drugs for Compassion →

Sponsor

Nanyang Technological University

Who can join

21 and older, any sex, with Mental Health Wellness 1 or Self Care. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Utilizing a Participatory Action Research (PAR) paradigm, this 12-month study will adopt a mixed method Waitlist Randomized Control Trial (RCT) with a built-in acceptability and feasibility study to test the efficacy of Slow Art Plus in reducing stress and empowering self-care among 200 participants.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Slow art plus: developing and piloting a single session art gallery-based intervention for mental health promotion via a mixed method waitlist randomized control trial.
Ho AHY, Ma SHX, Ng JT, Choo PY, et al · · 2024 · cited 1× · PMID 38803811 · DOI 10.3389/fpubh.2024.1238564

Verify or expand the search:

Other recruiting trials for Mental Health Wellness 1

Currently open trials in the same condition.

NCT07128095 — COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise · recruiting
NCT06254924 — Qoyangnuptu: Qoyangnuptu Intervention (QI) App · NA · recruiting
NCT06254872 — Qoyangnuptu: Peer Mentor · NA · recruiting
NCT05865782 — Reconstructing Schoolyards With Greenery to Increase Schoolchildren's Physical Activity and Mitigate Climate Changes · NA · recruiting
NCT05825040 — Randomized Controlled Trial on Precision Mental Health · NA · recruiting

Other Nanyang Technological University trials

Trials by the same sponsor.

NCT07425951 — Building Cognitive Behavioural Skills With StoryBooks to Reduce Emotional Difficulties in Kindergarten Years · NA · recruiting
NCT07497711 — Virtual Menstrual Pain Approaches in Females · Phase 2, PHASE3 · not yet recruiting
NCT07288892 — Effects of Pulsed Electromagnetic Field Therapy on Sport Performance and Recovery · NA · recruiting
NCT06991764 — Investigating the Effectiveness of a 2-week Novel Non-invasive Brain Stimulation Technique on Cognitive Outcomes in Heal · NA · not yet recruiting
NCT06732297 — Stronger Families Through Art Therapy: A Mixed Methods Programme Evaluation Study · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05803226 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nanyang Technological University
Last refreshed: 7 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05803226.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing